← Devices & Neurotechnology
Details checkedStrong evidenceCheckedcompany
Rexton Reach Hearing Aids
Also known as: Rexton Reach, Reach R-Li T, Reach R Plus, Multi-Voice Focus
Rexton
Company
Rexton
Program Type
Device
Modality
Hearing Aid/Software
Stage
Marketed
Status
Marketed
Target Gene
—
Route / Mode
External wearable prescription hearing aid platform
Confidence
87%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-06-10
Geography
United States, Europe, Global
Population
adult, age-related, post-lingual
Trial IDs
0
Mechanism
Rechargeable prescription receiver-in-canal hearing-aid platform using Multi-Voice Focus technology to preserve multiple conversational voices in noisy environments.
Indications
Notes
Adds a major Costco-visible WS Audiology secondary brand and its current multi-speaker speech-in-noise positioning to the prescription hearing-aid layer.
Evidence & Sources
2 structured sourcesKey Events
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed